Previous study was found that approximately half of CRLF2-rearranged BCR-ABL1-like B-ALL cases exhibited concomitant activating mutations in JAK2, whereas such mutations were rare in non-CRLF2-rearranged cases [80]. The gene discussed is CRLF2; the disease is acute lymphoblastic leukemia.